Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Director | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,971 |
Reported balance
After 2026-05-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 3,305 · Balance 57,971 F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs vest in full on the first anniversary of the grant date (the Vesting Date), provided that the director (a) remains a member of the Board of Directors of the issuer until the earlier of (i) such Vesting Date and (ii) the Company's Annual Shareholder Meeting in the year of such Vesting Date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2: Each RSU was granted on May 13, 2026, for no consideration. F3: Due to a clerical error, this number was previously overstated by 11 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 11 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs vest in full on the first anniversary of the grant date (the Vesting Date), provided that the director (a) remains a member of the Board of Directors of the issuer until the earlier of (i) such Vesting Date and (ii) the Company's Annual Shareholder Meeting in the year of such Vesting Date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.
F2: Each RSU was granted on May 13, 2026, for no consideration.
F3: Due to a clerical error, this number was previously overstated by 11 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 11 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2026 Filed May 15, 2026 20:07 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 3,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001740789-26-000002 · wk-form4_1778875618.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,971 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs vest in full on the first anniversary of the grant date (the Vesting Date), provided that the director (a) remains a member of the Board of Directors of the issuer until the earlier of (i) such Vesting Date and (ii) the Company's Annual Shareholder Meeting in the year of such Vesting Date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 13, 2026, for no consideration. F3 · balance_after: Due to a clerical error, this number was previously overstated by 11 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 11 shares. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:21 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 15,174 | $197.40 | $2,995,347.60 |
DisclosureSEC source: 0001740789-25-000003 · wk-form4_1763500903.xml · nonDerivative · entry 5 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,677 F5 · price: This is the weighted average sales price representing 15,174 shares sold at prices ranging from $197.00 to $197.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:21 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 24,076 | $196.61 | $4,733,582.36 |
DisclosureSEC source: 0001740789-25-000003 · wk-form4_1763500903.xml · nonDerivative · entry 4 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,851 F4 · price: This is the weighted average sales price representing 24,076 shares sold at prices ranging from $196.00 to $196.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:21 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 14,944 | $195.39 | $2,919,908.16 |
DisclosureSEC source: 0001740789-25-000003 · wk-form4_1763500903.xml · nonDerivative · entry 3 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,927 F3 · price: This is the weighted average sales price representing 14,944 shares sold at prices ranging from $195.00 to $195.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:21 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 17,594 | $194.49 | $3,421,857.06 |
DisclosureSEC source: 0001740789-25-000003 · wk-form4_1763500903.xml · nonDerivative · entry 2 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,871 F2 · price: This is the weighted average sales price representing 17,594 shares sold at prices ranging from $194.00 to $194.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:21 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 3,212 | $193.51 | $621,554.12 |
DisclosureSEC source: 0001740789-25-000003 · wk-form4_1763500903.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,465 F1 · price: This is the weighted average sales price representing 3,212 shares sold at prices ranging from $193.00 to $193.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:56 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-026563 · wk-form4_1747688199.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,677 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:19 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 13,162 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-023566 · wk-form4_1715804356.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,619 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date. F2 · price: Each RSU was granted on May 13, 2024 for no consideration. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:23 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 13,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018205 · wf-form4_168418220866282.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,457 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:20 UTC | INSMED Inc INSM · Entity 3174 | PurchaseCommon Stock | 45,000 | $17.69 | $796,050.00 |
DisclosureSEC source: 0001740789-22-000002 · wf-form4_166742043602523.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,265 Read SEC document |
| May 11, 2022 Filed May 13, 2022 22:16 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 14,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-019180 · form4.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,265 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 11, 2022, for no consideration. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:40 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 7,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-017428 · form4.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,620 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration. Read SEC document |
| May 12, 2020 Filed May 15, 2020 00:59 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 8,097 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-061856 · a4.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,062 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date. F2 · price: Each Restricted Stock Unit was granted on May 12, 2020 for no consideration. Read SEC document |
| May 15, 2019 Filed May 16, 2019 21:17 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 6,899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-19-000077 · edgar.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,965 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:12 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 6,066 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127430-18-000036 · edgar.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,066 F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date. F2 · price: Each Restricted Stock Unit was granted on May 15, 2018, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.